AVGO
40
-5
CFG
87
-2
KHC
29
-2
DOW
40
-2
ROP
38
-4
TXN
46
-2
NAVI
38
6
TMO
63
-3
SYF
65
-2
PPG
52
-2
DOV
63
-6
DTE
40
-5
AAP
5
-3
CA
42
12
GM
77
-3
TDC
63
-4
AMGN
31
-3
PX
60
-2
BMY
71
-3
ADP
51
-4
AVGO
40
-5
CFG
87
-2
KHC
29
-2
DOW
40
-2
ROP
38
-4
TXN
46
-2
NAVI
38
6
TMO
63
-3
SYF
65
-2
PPG
52
-2
DOV
63
-6
DTE
40
-5
AAP
5
-3
CA
42
12
GM
77
-3
TDC
63
-4
AMGN
31
-3
PX
60
-2
BMY
71
-3
ADP
51
-4
Financhill
Back

Legal & General Group Plc Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Sell
39

LGGNF
Legal & General Group Plc

Last Price:
$3.47
Seasonality Move:
3.4%
Sell
38

MNPR
Monopar Therapeutics, Inc.

Last Price:
$65.08
Seasonality Move:
9.84%
Sell
39
Legal & General Group Plc (LGGNF) is a Sell

Is Legal & General Group Plc a Buy, Sell or Hold?

  • The current Legal & General Group Plc [LGGNF] share price is $3.47. The Score for LGGNF is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • LGGNF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $65.30. The Score for MNPR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LGGNF Stock Price Chart

What is Legal & General Group Plc's stock price today?

  • The Legal & General Group Plc share price today is $3.47
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LGGNF is experiencing slight buying pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $65.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.

LGGNF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 56.46 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.31 - 3.45) Buy
Bollinger Bands (100): (3.17 - 3.43) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.92 Sell
Relative Strength Index (14 RSI): 34.74 Sell
Chaikin Money Flow: 193884 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (67.82 - 81.42) Sell
Bollinger Bands (100): (48.89 - 89.85) Sell

LGGNF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.45 Buy
20-day SMA: 3.38 Buy
50-day SMA: 3.29 Buy
200-day SMA: 3.33 Buy
8-day EMA: 3.44 Buy
20-day EMA: 3.39 Buy
50-day EMA: 3.29 Buy
200-day EMA: 2.19 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 68.19 Sell
20-day SMA: 72.23 Sell
50-day SMA: 78.7 Sell
200-day SMA: 53.66 Buy
8-day EMA: 67.77 Sell
20-day EMA: 71.75 Sell
50-day EMA: 74.63 Sell
200-day EMA: 57.45 Buy

Legal & General Group Plc Earnings Growth & LGGNF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.78 per share, and a decrease next year of $0.34 per share.

Legal & General Group Plc Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):